Base
NVOCC

CR BUSINESS DEVELOPMENT, LLC

Trade name: JCR LOGISTICS

MIAMI, FL, UNITED STATES

Cross-Source Intelligence

Arrivals (12 mo)

0

0 active ports

Active Ports

0

Distinct US ports with vessel activity

Compliance

Clear

6 lists screened

Data compiled from FMC Licensed Carriers & OTIs, OpenSanctions, OFAC SDN, BIS Consolidated Screening List · As of 2026-04-26 · Updates monthly

Sanctions & Compliance Screening

OFAC Specially Designated Nationals (SDN)

No matches found

Search of the OFAC SDN list for “CR BUSINESS DEVELOPMENT, LLC” returned no matches.

BIS Consolidated Screening List (CSL)

No matches found

Search of the BIS CSL for “CR BUSINESS DEVELOPMENT, LLC” returned no matches. This covers the BIS Entity List, Denied Persons List, OFAC SDN, ITAR Debarred, and 10 other U.S. export control lists.

SEC Filings (100)

020-30277
2023-03-15

SEC filing

View on SEC.gov →
001-36207
2015-03-16

OMNIBUS AMENDMENT BALTIMORE MARYLAND

View on SEC.gov →
333-292600
2026-01-07

S-1

View on SEC.gov →
333-292600
2026-01-15

424B3

View on SEC.gov →
000-53202
2019-02-22

EXHIBIT 10.50 THIRD AMENDED AND RESTATED CONSULTING AGREEMENT

View on SEC.gov →
333-292600
2026-03-17

424B3

View on SEC.gov →
000-53202
2016-02-25

CONSULTING AGREEMENT

View on SEC.gov →
020-31562
2022-12-30

SEC filing

View on SEC.gov →
333-233255
2022-02-16

FWP

View on SEC.gov →
020-24220
2019-04-30

FORM C-AR

View on SEC.gov →
000-54653
2022-07-07

UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF CR REWARD AT OF AND FOR THE PERIOD ENDED MARCH 31, 2022 AND THE RELATED NOTES THERETO

View on SEC.gov →
333-292600
2026-03-03

POS AM

View on SEC.gov →
001-13610
2022-02-16

EX-99.1

View on SEC.gov →
000-54653
2022-07-07

AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF CR REWARD AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020, THE RELATED NOTES THERETO, AND THE INDEPENDENT AUDITOR'S REPORT THEREON

View on SEC.gov →
001-36177
2026-02-26

10-K

View on SEC.gov →
333-292600
2026-02-26

424B3

View on SEC.gov →
001-38443
2020-11-30

EX-99.1

View on SEC.gov →
000-29643
2012-04-24

10-K/A

View on SEC.gov →
000-50767
2008-11-05

EX-99.3 RISK FACTORS OF THE REGISTRANT

View on SEC.gov →
001-33500
2008-08-11

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2008

View on SEC.gov →
000-53202
2018-03-02

CORNERSTONE RESOURCES LLC SECOND AMENDED AND RESTATED CONSULTING AGREEMENT

View on SEC.gov →
005-59693
2009-06-12

SEC filing

View on SEC.gov →
333-285035
2025-12-12

EX-99.4

View on SEC.gov →
001-13038
2005-08-05

FORM 10-Q

View on SEC.gov →
005-59693
2009-11-05

SEC filing

View on SEC.gov →
333-42293333-89194-01
2005-11-04

FORM 10-Q

View on SEC.gov →
001-13038
2005-11-03

FORM 10-Q

View on SEC.gov →
132-02240
2002-04-19

RELIANT PHARMACEUTICALS, LLC

View on SEC.gov →
001-33500
2009-05-07

FORM 10-Q

View on SEC.gov →
333-42293333-89194-01
2005-08-08

FORM 10-Q

View on SEC.gov →
001-33500
2009-08-14

FORM 10-Q

View on SEC.gov →
001-33500
2008-05-15

FORM 10-Q

View on SEC.gov →
001-15697
2009-03-23

SEC filing

View on SEC.gov →
001-36177
2025-06-18

EXHIBIT 99.3

View on SEC.gov →
001-33500
2008-11-14

FORM 10-Q

View on SEC.gov →
001-15697
2004-01-08

EXHIBIT 99.1

View on SEC.gov →
24R-00602
2022-05-03

SEC filing

View on SEC.gov →
001-13038
2005-05-09

FORM 10-Q

View on SEC.gov →
333-136910
2006-10-27

CRITICAL THERAPEUTICS, INC.

View on SEC.gov →
001-36177
2025-12-04

8-K

View on SEC.gov →
333-136910
2006-10-27

CRITICAL THERAPEUTICS, INC.

View on SEC.gov →
333-42293333-89194-01
2005-05-09

FORM 10-Q

View on SEC.gov →
000-50767
2009-05-07

CORNERSTONE THERAPEUTICS INC.

View on SEC.gov →
002-69494
2005-11-14

QUARTERLY FILING

View on SEC.gov →
333-285035
2025-12-12

EX-99.3

View on SEC.gov →
000-29643
2012-03-23

10-K

View on SEC.gov →
001-33500
2010-05-06

FORM 10-Q

View on SEC.gov →
001-33500
2009-11-06

FORM 10-Q

View on SEC.gov →
002-69494
2005-11-01

EX-10.3 - JOINT VENTURE AGREEMENT

View on SEC.gov →
333-215274
2018-02-08

CCPT V SUPPLEMENT NO. 11

View on SEC.gov →
001-36177
2025-06-18

EXHIBIT 99.2

View on SEC.gov →
001-33500
2010-03-04

FORM 10-K

View on SEC.gov →
333-103799
2004-11-12

EXHIBIT 10.350

View on SEC.gov →
001-33500
2009-03-26

FORM 10-K

View on SEC.gov →
024-11374
2021-06-08

PART II AND III

View on SEC.gov →
000-56214
2023-12-27

FINANCIAL STATEMENTS

View on SEC.gov →
333-149290
2009-03-31

FORM 10-K

View on SEC.gov →
333-149290
2010-03-29

FORM 10-K

View on SEC.gov →
000-50767
2009-03-26

CORNERSTONE THERAPEUTICS INC.

View on SEC.gov →
333-141164
2007-06-01

FILED PURSUANT TO RULE 424(B)(4)

View on SEC.gov →
333-189891
2015-03-31

10-K CCPT V 12.31.2014

View on SEC.gov →
000-54530
2021-03-31

FORM 10-K

View on SEC.gov →
000-50767
2006-10-27

EX-99.1 PRESS RELEASE ISSUED BY THE COMPANY ON OCTOBER 27, 2006

View on SEC.gov →
024-11374
2021-07-06

PART II AND III

View on SEC.gov →
132-02240
2002-03-21

ALKERMES, INC.

View on SEC.gov →
333-151592
2008-06-11

FORM S-3

View on SEC.gov →
000-52293
2008-09-03

AMENDMENT TO THE ANNUAL REPORT

View on SEC.gov →
000-29643
2013-03-20

10-K

View on SEC.gov →
000-54939
2014-03-31

10-K

View on SEC.gov →
000-50767
2009-11-04

CORNERSTONE THERAPEUTICS INC.

View on SEC.gov →
000-28508
2012-05-24

EXHIBIT 99.3

View on SEC.gov →
001-33500
2011-03-08

FORM 10-K

View on SEC.gov →
001-36177
2025-11-06

10-Q

View on SEC.gov →
000-24635
2003-07-28

AMENDMENT TO FORM 10-KSB

View on SEC.gov →
333-285035
2025-12-12

EX-99.2

View on SEC.gov →
333-141164
2007-05-31

AMENDMENT NO. 5 TO REGISTRATION STATEMENT ON FORM S-1

View on SEC.gov →
333-164058
2010-04-01

SEC filing

View on SEC.gov →
000-26520
2010-03-31

SEC filing

View on SEC.gov →
333-285035
2025-03-17

SEC filing

View on SEC.gov →
2005-09-16

SEC filing

View on SEC.gov →
000-55437
2016-03-30

CCPT V 12/31/2015 10-K

View on SEC.gov →
001-13561
2019-04-30

10-Q

View on SEC.gov →
000-55437
2018-03-30

CCPT V 10-K 12/31/2017

View on SEC.gov →
333-141164
2007-05-17

AMENDMENT NO. 3 TO REGISTRATION STATEMENT ON FORM S-1

View on SEC.gov →
000-56214
2024-02-02

AUDITED FINANCIAL STATEMENTS

View on SEC.gov →
001-33500
2010-08-11

FORM 10-Q

View on SEC.gov →
333-156810
2010-04-01

SEC filing

View on SEC.gov →
333-72118
2001-10-23

REGISTRATION STATEMENT

View on SEC.gov →
001-36177
2025-07-31

10-Q

View on SEC.gov →
000-50767
2009-08-11

CORNERSTONE THERAPEUTICS INC.

View on SEC.gov →
333-141164
2007-05-24

AMENDMENT NO. 4 TO REGISTRATION STATEMENT ON FORM S-1

View on SEC.gov →
333-149290
2008-10-09

COLE CREDIT PROPERTY TRUST III, INC.

View on SEC.gov →
001-41148
2023-05-17

425

View on SEC.gov →
333-169533
2013-03-29

CCPT IV 10-K

View on SEC.gov →
000-50767
2006-10-27

CRITICAL THERAPEUTICS, INC.

View on SEC.gov →
333-110858
2007-09-20

NEOPROBE CORPORATION POS AM

View on SEC.gov →
333-149290
2008-07-24

COLE CREDIT PROPERTY TRUST, III, INC.

View on SEC.gov →
000-54530
2020-05-27

FORM 10-K

View on SEC.gov →
333-141164
2007-04-20

AMENDMENT NO. 2 TO FORM S-1

View on SEC.gov →
083-00002
2025-05-28

DSTRBRPT

View on SEC.gov →

Source: SEC EDGAR Full-Text Search

Registry Details

FMC OTI Number
033113
License Status
Active
Bond Status
Bonded — UNITED STATES FIRE INSURANCE COMPANY
Address
500 BRICKELL AVE., SUITE 2908, MIAMI, FL, UNITED STATES
Classification
NVOCC

Data Sources

Compliance Screening

No sanctions match

No exact name match found in OpenSanctions global database. This is not a guarantee of compliance — always verify through official channels.

Source: OpenSanctions (OFAC SDN, EU, UN, and 40+ additional lists)

Screening Tools

Search the Consolidated Screening List (BIS, OFAC, DDTC) and global sanctions lists.

Search Screening List
← DIRECT FRESH WHOLESALE & EXPORT, INC.G & D EXPRESS TRANSPORT, LLC. →